Genomics-Enhanced Rapid COVID-19 Pandemic Response [Funder: Genome Alberta, Alberta Children's Hospital Research]

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    Other Funders (Canada)
  • Principal Investigator

    Matthew Croxen, Linda Chui
  • Research Location

    Canada
  • Lead Research Institution

    Alberta Precision Laboratories
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

In just three months, the COVID-19 pandemic has greatly impacted global health and economy. As of April 21st, 2020, there are over 2.5 million cases worldwide; at the time of writing 40,000 of those are in Canada. Many more people are expected to die as a direct result of COVID-19, but understanding the spread of the virus will help mitigation efforts. Mutations are common and expected in coronaviruses genomes. We can take advantage of these mutations to track the spread of the viruses in the community, providing vital public health information on the movement and potential sources of disease. At the time of writing there are over 3,095 cases in Alberta. To improve on the speed in generating this genetic information, we will work with the University of Calgary Centre for Health Genomics and Informatics (CHGI) to rapidly generate genetic sequences over 1,900 of these viruses (we expect more cases with time). Meanwhile, we will also validate automated methods to rapidly sequence viral genomes at the Public Health Laboratory on an ongoing basis. This automation process can be deployed in other laboratories across the world. The genetic information that we generate from the Alberta COVID-19 viruses will be jointly analyzed along with 1000s of other COVID-19 viruses from across the world. This information will help public health better understand the dynamics of viral spread in Alberta, so that policies to stop disease spread can be used more effectively, as well as provide important information for diagnostics, therapeutics, and vaccine development.